About Us

Our Partners & Investors

Boston Scientific and Functional Neuromodulation entered into a strategic investment partnership in 2016 to further develop DBS of the fornix for mild Alzheimer's disease patients.

Functional Neuromodulation recently closed a $10.4 million round of financing with Genesys Capital, one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.

CAUTION — Investigational device. Limited by Federal law to investigational use.